1-20 of 60
Stephanie Ma
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 7: Lipid-driven oxidative phosphorylation fuels lymph node colonization by esophageal tumor cells

Shanshan Li, Baifeng Zhang, Cuicui Huang, Yuying Zhao, Stephanie Ma, Xinyuan Guan
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 7.
https://doi.org/10.1158/1538-7445.AM2025-7
Published: 21 April 2025
View articletitled, Abstract 7: Lipid-driven oxidative phosphorylation fuels lymph node colonization by esophageal tumor cells
Journal Articles

PROX1: a key regulator of hepatocyte identity and tumorigenesis

Terence Kin Wah. Lee, Stephanie Ma
Journal: Cancer Research
Cancer Res (2025)
https://doi.org/10.1158/0008-5472.CAN-25-1377
Published: 31 March 2025
View articletitled, PROX1: a key regulator of hepatocyte identity and tumorigenesis
Open the PDF for PROX1: a key regulator of hepatocyte identity and tumorigenesis in another window
Journal Articles

Abstract 5437: Chemoproteomics-enabled discovery of covalent inhibitors targeted at AGPAT4: Unravelling tumor lineage plasticity to overcome drug resistance in hepatocellular carcinoma

Kai-Yu Ng, Tin-Yan Koo, Tsz-Lok Fong, Ya Gao, Tin-Lok Wong, Yuan Gao, Jing-Ping Yun, Xin-Yuan Guan, Ming Liu, Clive YS Chung, Stephanie Ma
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 5437.
https://doi.org/10.1158/1538-7445.AM2024-5437
Published: 22 March 2024
View articletitled, Abstract 5437: Chemoproteomics-enabled discovery of covalent inhibitors targeted at AGPAT4: Unravelling tumor lineage plasticity to overcome drug resistance in hepatocellular carcinoma
Journal Articles

Abstract 4667: HDAC9 as a potential regulator of lenvatinib resistance in hepatocellular carcinoma

Yunong Xie, Minghe Zhang, Yan Liu, Linglin Liu, Alfred Sze-Lok Cheng, Stephanie Ma, Man Tong
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 4667.
https://doi.org/10.1158/1538-7445.AM2024-4667
Published: 22 March 2024
View articletitled, Abstract 4667: HDAC9 as a potential regulator of lenvatinib resistance in hepatocellular carcinoma
Journal Articles

Abstract 1988: Mass spectrometry profiling identifies ENO2 as a driver of lenvatinib resistance in hepatocellular carcinoma

Sukbum Kim, Jia-Jian Loh, Huajian Yu, Ki-Fong Man, Kai-Yu Ng, Terence Kin-Wah Lee, Clive Yik-Sham Chung, Stephanie Ma
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 1988.
https://doi.org/10.1158/1538-7445.AM2024-1988
Published: 22 March 2024
View articletitled, Abstract 1988: Mass spectrometry profiling identifies ENO2 as a driver of lenvatinib resistance in hepatocellular carcinoma
Journal Articles

Abstract 7065: AMBRA1 coordinates mitochondrial function to regulate cancer stemness and tumorigenesis in hepatocellular carcinoma

Yan Liu, Yunong Xie, Yimiao He, Stephanie Ma, Man Tong
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 7065.
https://doi.org/10.1158/1538-7445.AM2024-7065
Published: 22 March 2024
View articletitled, Abstract 7065: AMBRA1 coordinates mitochondrial function to regulate cancer stemness and tumorigenesis in hepatocellular carcinoma
Journal Articles

Abstract 6490: Pt1a and sorafenib combination treatment exerts synergistic anti-hepatocellular carcinoma effect through RNA m6A methylation modification

Yinjia Huang, Yalu Cui, Ianto Bosheng Huang, Yanyan Wang, Yang Xuan, Pui Ki Wan, Chun Nam Lok, Chi Ming Che, Stephanie Ma
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 6490.
https://doi.org/10.1158/1538-7445.AM2024-6490
Published: 22 March 2024
View articletitled, Abstract 6490: Pt1a and sorafenib combination treatment exerts synergistic anti-hepatocellular carcinoma effect through RNA m6A methylation modification
Journal Articles

Abstract 7597: Therapeutic potential of ketogenic diet as an adjuvant to lenvatinib treatment in hepatocellular carcinoma

Minghe Zhang, Terence Kin-Wah Lee, Stephanie Ma, Man Tong
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 7597.
https://doi.org/10.1158/1538-7445.AM2024-7597
Published: 22 March 2024
View articletitled, Abstract 7597: Therapeutic potential of ketogenic diet as an adjuvant to lenvatinib treatment in hepatocellular carcinoma
Journal Articles

Abstract 5447: Microtubule-associated protein MAP2 promotes drug resistance and cancer stemness in hepatocellular carcinoma through integrin dysregulation

Ut Kei Lou, Ka-Hei Lam, Huajian Yu, Jia Jian Loh, Ki-Fong Man, Lei Zhou, Yuan Gao, Tin-Lok Wong, Cheng-Han Yu, Stephanie Ma
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 5447.
https://doi.org/10.1158/1538-7445.AM2024-5447
Published: 22 March 2024
View articletitled, Abstract 5447: Microtubule-associated protein MAP2 promotes drug resistance and cancer stemness in hepatocellular carcinoma through integrin dysregulation
Journal Articles

Abstract 1755: ADAR1-mediated RNA editing of SCD1 links lipid metabolism to gastric cancer drug resistance and self-renewal

Jia Jian Loh, Tin Lok Wong, Shixun Lu, Helen HN Yan, Hoi Cheong Siu, Ren Xi, Dessy Chan, Max JF Kam, Lei Zhou, Man Tong, John A. Copland, Leilei Chen, Jingping Yun, Suet Yi Leung, Stephanie Ma
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 1755.
https://doi.org/10.1158/1538-7445.AM2023-1755
Published: 04 April 2023
View articletitled, Abstract 1755: ADAR1-mediated RNA editing of SCD1 links lipid metabolism to gastric cancer drug resistance and self-renewal
Journal Articles

Abstract 395: Resistance to tyrosine kinase inhibitor confers an immunosuppressive microenvironment and cross-resistance to immunotherapy through AXL/PDPK1 axis in liver cancer

Yunong Xie, Bosheng Huang, Huajian Yu, Jia-Jian Loh, Rainbow Wing-Hei Leung, Terence Lee, Stephanie Ma, Man Tong
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 395.
https://doi.org/10.1158/1538-7445.AM2023-395
Published: 04 April 2023
View articletitled, Abstract 395: Resistance to tyrosine kinase inhibitor confers an immunosuppressive microenvironment and cross-resistance to immunotherapy through AXL/PDPK1 axis in liver cancer
Journal Articles

Abstract 2433: SERPINA12 promotes the tumorigenic capacity of hepatocellular carcinoma stem cells through hyperactivation of AKT/β-catenin signaling

Huajian Yu, Lei Zhou, Jane Ho-Chun Loong, Ka-Hei Lam, Tin-Lok Wong, Kai-Yu Ng, Man Tong, Victor WS Ma, Yanyan Wang, Xiang Zhang, Terence K Lee, Jing-Ping Yun, Jun Yu, Stephanie Ma
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 2433.
https://doi.org/10.1158/1538-7445.AM2023-2433
Published: 04 April 2023
View articletitled, Abstract 2433: SERPINA12 promotes the tumorigenic capacity of hepatocellular carcinoma stem cells through hyperactivation of AKT/β-catenin signaling
Journal Articles

Abstract 4135: A novel plasma cell-based mechanism of action of adenosine immunomodulation and A2AR antagonism

Chiara Martinoli, Paola Tieppo, Marjorie Mercier, Hussein Shehade, Noemie Wald, Anais Vezzu, Annelise Hermant, Boris Pirlot, Stephanie Ma, Maurizio Ceppi, Yvonne McGrath, Maura Rossetti
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 4135.
https://doi.org/10.1158/1538-7445.AM2023-4135
Published: 04 April 2023
View articletitled, Abstract 4135: A novel plasma cell-based mechanism of action of adenosine immunomodulation and A2AR antagonism
Journal Articles

Abstract 2429: AGPAT4 as a novel metabolic driver of oncogenic stemness and dedifferentiation in hepatocellular carcinoma

Kai Yu Ng, Tsz-Lok Fong, Ya Gao, Tin-Lok Wong, Yuan Gao, Jing-Ping Yun, Xin-Yuan Guan, Ming Liu, Clive YS Chung, Stephanie Ma
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 2429.
https://doi.org/10.1158/1538-7445.AM2023-2429
Published: 04 April 2023
View articletitled, Abstract 2429: AGPAT4 as a novel metabolic driver of oncogenic stemness and dedifferentiation in hepatocellular carcinoma
Journal Articles

Abstract 5799: SPINK1-induced tumor plasticity provides a therapeutic window for chemotherapy in hepatocellular carcinoma

Ki-Fong Man, Lei Zhou, Ying-Tung Lam, Jun Yu, Jing-Ping Yun, Xin-Yuan Guan, Ming Liu, Stephanie Ma
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 5799.
https://doi.org/10.1158/1538-7445.AM2023-5799
Published: 04 April 2023
View articletitled, Abstract 5799: SPINK1-induced tumor plasticity provides a therapeutic window for chemotherapy in hepatocellular carcinoma
Journal Articles

Caspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular Carcinoma

Etienne Ho Kit Mok, Carmen Oi Ning Leung, Lei Zhou, Martina Mang Leng Lei, Hoi Wing Leung, Man Tong, Tin Lok Wong, Eunice Yuen Ting Lau, Irene Oi Lin Ng, Jin Ding, Jing Ping Yun, Jun Yu, Hui Lian Zhu, Chi Ho Lin, Dan Lindholm, Kit Sum Leung, Jonathan D. Cybulski, David M. Baker, Stephanie Ma, Terence Kin Wah Lee
Journal: Cancer Research
Cancer Res (2022) 82 (17): 3102–3115.
https://doi.org/10.1158/0008-5472.CAN-21-2934
Published: 02 September 2022
View articletitled, Caspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular Carcinoma
Open the PDF for Caspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular Carcinoma in another window
Includes: Supplementary data
Journal Articles

Abstract 6124: Interleukin-1β and exosomal M6PR secreted by serglycin-overexpressing esophageal cancer cells instigate fibroblasts and endothelial cells to promote esophageal cancer progression

Dongdong Yan, Di Cui, Yun Zhu, Cecilia Ka Wing Chan, Chung Hang Jonathan Choi, Tengfei Liu, Sai Wah Tsao, Stephanie Ma, Annie Lai-Man Cheung
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 6124.
https://doi.org/10.1158/1538-7445.AM2022-6124
Published: 15 June 2022
View articletitled, Abstract 6124: Interleukin-1β and exosomal M6PR secreted by serglycin-overexpressing esophageal cancer cells instigate fibroblasts and endothelial cells to promote esophageal cancer progression
Journal Articles

A Combinatorial CRISPR–Cas9 Screen Identifies Ifenprodil as an Adjunct to Sorafenib for Liver Cancer Treatment

Feng Xu, Man Tong, Cindy S.W. Tong, Becky K.C. Chan, Hoi Yee Chu, Tin Lok Wong, John H.C. Fong, Maggie S.H. Cheung, Kylie Hin-Man Mak, Lakhansing Pardeshi, Yuanhua Huang, Koon Ho Wong, Gigi C.G. Choi, Stephanie Ma, Alan S.L. Wong
Journal: Cancer Research
Cancer Res (2021) 81 (24): 6219–6232.
https://doi.org/10.1158/0008-5472.CAN-21-1017
Published: 15 December 2021
View articletitled, A Combinatorial CRISPR–Cas9 Screen Identifies Ifenprodil as an Adjunct to Sorafenib for Liver Cancer Treatment
Open the PDF for A Combinatorial CRISPR–Cas9 Screen Identifies Ifenprodil as an Adjunct to Sorafenib for Liver Cancer Treatment in another window
Includes: Supplementary data
Journal Articles

FSTL1 Secreted by Activated Fibroblasts Promotes Hepatocellular Carcinoma Metastasis and Stemness

Jia-Jian Loh, Tsz-Wai Li, Lei Zhou, Tin-Lok Wong, Xue Liu, Victor W.S. Ma, Chung-Mau Lo, Kwan Man, Terence K. Lee, Wen Ning, Man Tong, Stephanie Ma
Journal: Cancer Research
Cancer Res (2021) 81 (22): 5692–5705.
https://doi.org/10.1158/0008-5472.CAN-20-4226
Published: 15 November 2021
View articletitled, FSTL1 Secreted by Activated Fibroblasts Promotes Hepatocellular Carcinoma Metastasis and Stemness
Open the PDF for FSTL1 Secreted by Activated Fibroblasts Promotes Hepatocellular Carcinoma Metastasis and Stemness in another window
Includes: Supplementary data
Journal Articles

EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma

Hoi Wing Leung, Carmen Oi Ning Leung, Eunice Y. Lau, Katherine Po Sin Chung, Etienne H. Mok, Martina Mang Leng Lei, Rainbow Wing Hei Leung, Man Tong, Vincent W. Keng, Cong Ma, Qian Zhao, Irene Oi Lin Ng, Stephanie Ma, Terence K. Lee
Journal: Cancer Research
Cancer Res (2021) 81 (12): 3229–3240.
https://doi.org/10.1158/0008-5472.CAN-21-0184
Published: 15 June 2021
View articletitled, EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma
Open the PDF for EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma in another window
Includes: Supplementary data